IDiyas

For the Inventor, By the Inventor

Madrid, Spain

Sagrario M Del Val

USPTO Granted Patents = 12

Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 78(Granted Patents)


Location History:

  • Pez Volador, ES (1991)
  • Madrid, ES (1976 - 1992)

Company Filing History:

goldMedal12 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1976-1992

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5091413 - Antibiotic agent (1992-02-25),
2. 5064856 - Novel HMG-CoA synthase inhibitors (1991-11-12),
3. 4981980 - Drug for treating manic depression (1991-01-01),
4. 4968608 - Process for antifungal fermentation product (1990-11-06),
5. 4960698 - Process for producing L-654,040, antibacterial agent (1990-10-02),
6. 4956294 - Culture of Streptoverticillium synroense for producing an antibacterial (1990-09-11),
7. 4952604 - Antifungal agent (1990-08-28),
8. 4931352 - Antifungal fermentation product (1990-06-05),
9. 4828992 - Process for the manufacture of an antifungal antihypercholesterolemic .beta (1989-05-09),
10. 4681846 - Process for the preparation of difficidin and derivative antibacterials (1987-07-21),
11. 4545991 - Difficidin and derivative antibacterials (1985-10-08),
12. 3935309 - Synergistic combinations of phosphonomycin and bacteriostatic agents (1976-01-27),

Title: Celebrating the Innovations of Sagrario M Del Val

Introduction: Sagrario M Del Val, an accomplished inventor based in Madrid, Spain, has made significant contributions to the field of microbiology and pharmaceutical science through her innovative work. With a remarkable portfolio of 12 patents, Sagrario is at the forefront of developing antibiotic agents and HMG-CoA synthase inhibitors that have the potential to revolutionize treatment options.

Latest Patents: Among her most notable patents, Sagrario has developed an antibiotic agent derived from the cultivation of Dictyochaeta simplex. This compound showcases broad antifungal activity and is also effective against pneumocystis infections. Additionally, she holds patents for novel HMG-CoA synthase inhibitors, which are designed to exhibit antifungal activity, demonstrating her commitment to addressing critical health challenges.

Career Highlights: Sagrario M Del Val is currently employed at Merck & Company, Inc., a leading global pharmaceutical company known for its dedication to advancing healthcare through innovation. Her role in the research and development department has allowed her to focus on creating impactful healthcare solutions that contribute to the well-being of individuals worldwide.

Collaborations: Throughout her career, Sagrario has collaborated with esteemed colleagues Richard L Monaghan and Otto D Hensens. These partnerships have facilitated the exchange of ideas and have propelled significant advancements in the development of her patented inventions.

Conclusion: Sagrario M Del Val exemplifies the spirit of innovation in the pharmaceutical industry. Her pioneering patents not only highlight her ingenuity but also reflect her dedication to improving health outcomes. As she continues her work at Merck & Company, Inc., the scientific community eagerly anticipates her future contributions and the impact they will have on modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…